- Home
- XBIT vs CDLX Comparison
XBIT vs CDLX Comparison
Compare XBIT & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- CDLX
- Stock Information
- Founded
- XBIT 2005
- CDLX 2008
- Country
- XBIT United States
- CDLX United States
- Employees
- XBIT N/A
- CDLX N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- CDLX Computer Software: Programming Data Processing
- Sector
- XBIT Health Care
- CDLX Technology
- Exchange
- XBIT Nasdaq
- CDLX Nasdaq
- Market Cap
- XBIT 194.5M
- CDLX 180.4M
- IPO Year
- XBIT 2015
- CDLX 2018
- Fundamental
- Price
- XBIT $3.40
- CDLX $3.00
- Analyst Decision
- XBIT
- CDLX Hold
- Analyst Count
- XBIT 0
- CDLX 6
- Target Price
- XBIT N/A
- CDLX $5.90
- AVG Volume (30 Days)
- XBIT 52.0K
- CDLX 979.5K
- Earning Date
- XBIT 03-14-2025
- CDLX 03-13-2025
- Dividend Yield
- XBIT N/A
- CDLX N/A
- EPS Growth
- XBIT N/A
- CDLX N/A
- EPS
- XBIT N/A
- CDLX N/A
- Revenue
- XBIT N/A
- CDLX $293,468,000.00
- Revenue This Year
- XBIT N/A
- CDLX N/A
- Revenue Next Year
- XBIT N/A
- CDLX $3.49
- P/E Ratio
- XBIT N/A
- CDLX N/A
- Revenue Growth
- XBIT N/A
- CDLX N/A
- 52 Week Low
- XBIT $3.25
- CDLX $2.76
- 52 Week High
- XBIT $9.96
- CDLX $20.52
- Technical
- Relative Strength Index (RSI)
- XBIT 26.88
- CDLX 36.80
- Support Level
- XBIT $3.40
- CDLX $2.76
- Resistance Level
- XBIT $3.69
- CDLX $4.05
- Average True Range (ATR)
- XBIT 0.20
- CDLX 0.26
- MACD
- XBIT 0.05
- CDLX -0.04
- Stochastic Oscillator
- XBIT 3.85
- CDLX 10.69
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.